C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
{{output}}
From asymptomatic to severe, SARS-CoV-2, causative agent of COVID-19, elicits varying disease severities. Moreover, understanding innate and adaptive immune responses to SARS-CoV-2 is imperative since variants such as Omicron negatively impact adaptive antibod... ...